G1 Therapeutics
Why Robinhood?
You can watch GTHX and buy or sell other stocks, ETFs, and their options commission-free!About GTHX
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib.
GTHX Key Statistics
Stock Snapshot
As of today, G1 Therapeutics(GTHX) shares are valued at $7.15. The company's market cap stands at 377.22M, with a P/E ratio of -8.30.
On 2026-05-14, G1 Therapeutics(GTHX) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for G1 Therapeutics(GTHX) stock has reached 0, versus its average volume of 651.38K.
Over the past 52 weeks, G1 Therapeutics(GTHX) stock has traded between a high of $7.19 and a low of $1.08.
Over the past 52 weeks, G1 Therapeutics(GTHX) stock has traded between a high of $7.19 and a low of $1.08.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.